Whitehawk Therapeutics Stock Price Patterns
| WHWK Stock | 2.76 0.05 1.85% |
Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Current Year (0.25) | EPS Estimate Next Year (1.16) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.17) | Quarterly Revenue Growth 0.335 |
Using Whitehawk Therapeutics hype-based prediction, you can estimate the value of Whitehawk Therapeutics from the perspective of Whitehawk Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Whitehawk Therapeutics using Whitehawk Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Whitehawk using crowd psychology based on the activity and movement of Whitehawk Therapeutics' stock price.
Whitehawk Therapeutics Implied Volatility | 2.48 |
Whitehawk Therapeutics' implied volatility exposes the market's sentiment of Whitehawk Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Whitehawk Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Whitehawk Therapeutics stock will not fluctuate a lot when Whitehawk Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Whitehawk Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Whitehawk because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Whitehawk Therapeutics after-hype prediction price | USD 2.72 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Whitehawk | Build AI portfolio with Whitehawk Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Whitehawk Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Whitehawk Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Whitehawk Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Whitehawk Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Whitehawk Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Whitehawk Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Whitehawk Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Whitehawk Therapeutics' historical news coverage. Whitehawk Therapeutics' after-hype downside and upside margins for the prediction period are 0.14 and 6.95, respectively. We have considered Whitehawk Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Whitehawk Therapeutics is unstable at this time. Analysis and calculation of next after-hype price of Whitehawk Therapeutics is based on 3 months time horizon.
Whitehawk Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Whitehawk Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Whitehawk Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Whitehawk Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 4.23 | 0.04 | 0.08 | 8 Events / Month | 4 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.76 | 2.72 | 1.45 |
|
Whitehawk Therapeutics Hype Timeline
Whitehawk Therapeutics is at this time traded for 2.76. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of 0.08. Whitehawk is anticipated to decline in value after the next headline, with the price expected to drop to 2.72. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.45%, whereas the daily expected return is at this time at 0.47%. The volatility of related hype on Whitehawk Therapeutics is about 2464.08%, with the expected price after the next announcement by competition of 2.84. About 12.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.88. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Whitehawk Therapeutics recorded a loss per share of 0.64. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 27th of August 2021. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Whitehawk Therapeutics Basic Forecasting Models to cross-verify your projections.Whitehawk Therapeutics Related Hype Analysis
Having access to credible news sources related to Whitehawk Therapeutics' direct competition is more important than ever and may enhance your ability to predict Whitehawk Therapeutics' future price movements. Getting to know how Whitehawk Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Whitehawk Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GOVX | GeoVax Labs | 0.65 | 9 per month | 0.00 | (0.29) | 9.38 | (13.70) | 42.89 | |
| BLRX | BioLineRx | 0.05 | 7 per month | 0.00 | (0.08) | 5.20 | (5.26) | 13.04 | |
| THAR | Tharimmune | 0.08 | 10 per month | 5.92 | 0.08 | 11.55 | (10.08) | 40.06 | |
| AIMD | Ainos Inc | (0.06) | 9 per month | 0.00 | (0.11) | 12.30 | (10.43) | 38.73 | |
| LPCN | Lipocine | 0.49 | 9 per month | 3.32 | 0.28 | 15.95 | (7.33) | 33.09 | |
| ICU | SeaStar Medical Holding | (0.18) | 9 per month | 0.00 | (0.15) | 9.58 | (9.88) | 34.66 |
Whitehawk Therapeutics Additional Predictive Modules
Most predictive techniques to examine Whitehawk price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Whitehawk using various technical indicators. When you analyze Whitehawk charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Whitehawk Therapeutics Predictive Indicators
The successful prediction of Whitehawk Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Whitehawk Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Whitehawk Therapeutics based on analysis of Whitehawk Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Whitehawk Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Whitehawk Therapeutics's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.0185 | 0.0165 | Price To Sales Ratio | 3.78 | 3.59 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Whitehawk Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Whitehawk Stock please use our How to buy in Whitehawk Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Whitehawk Therapeutics. Anticipated expansion of Whitehawk directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Whitehawk Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.64) | Revenue Per Share | Quarterly Revenue Growth 0.335 | Return On Assets | Return On Equity |
Investors evaluate Whitehawk Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Whitehawk Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Whitehawk Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Whitehawk Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Whitehawk Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Whitehawk Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.